US Startup Research Product — US Startup Research Product — IoT Wrist Band Sync Tablet App — Maternal Wrist

The challenge

Every year, about 14 million people experience severe blood loss after giving birth, or postpartum hemorrhage. Hemorrhage is the global leading cause of maternal death, and for every person who dies, 100 more suffer devastating complications. In the US, hemorrhage occurs in 5% of all births and accounts for 11% of all maternal deaths. These tragic losses cost the US healthcare system $1.8 billion each year. Yet 90% of cases are preventable with early detection and treatment.

What we built

Maternal Wrist is a wrist-worn sensor that provides objective, real-time insights into a patient's hemorrhage risk. Maternal Wrist technology enables equitable, low-cost, early hemorrhage detection and treatment monitoring — even when blood loss is internal. The key to the breakthrough technology lies in its ability to capture the subtle nuances of peripheral blood flow, independent of skin pigmentation, and the telltale signs of early hemorrhage as the body instinctively redirects blood to protect vital organs. The wearable tirelessly monitors these intricate shifts, providing real-time and quantitative insights to healthcare providers.

Outcome

The system went live on schedule and is in active use today. As with every Kirshi Technologies engagement, delivery was sprint-based with measurable milestones at each stage, and US Startup Research Product retained full intellectual property ownership of all custom code from day one.

Technologies

Wearable Hemorrhage Detection Tablet Sync Clinical